Abstract
There will be an estimated 58,240 new cases and 13,040 deaths from kidney cancer in the USA in 2010 [1]. Compared to 1971, this represents a fivefold increase in the incidence and twofold increase in the mortality of renal cancer. Associated risk factors for kidney cancer include hypertension, obesity, and African American race. Epidemiological evidence suggests an increase in all stages of renal cancer, including the advanced and metastatic cases. It is now understood that renal cortical tumors are a family of distinct tumors with variable histology, cytogenetic defects, and metastatic potential [2]. Approximately 90% of the tumors that metastasize are the conventional clear cell carcinoma [3]; however, they account for only 54% of the total number of resected tumors. Approximately 30–40% of renal tumor patients will either present with or later develop metastatic disease. The widespread use of the modern abdominal imaging techniques (CT, MRI, and abdominal ultrasound) over the last two decades, usually ordered to evaluate nonspecific abdominal and musculoskeletal complaints or during unrelated cancer care, has changed the profile of the typical renal tumor patient from one with a massive, symptomatic tumor at presentation to one with a small, asymptomatic, renal mass (<4 cm) incidentally discovered in 70% of the cases [4]. A survival rate of 90% or greater, depending on the tumor histology, is expected for these small tumors if partial (PN) or radical nephrectomy (RN) is performed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics 2010. CA Cancer J Clin. 2010;60(5):277–300.
Linehan WM, Walther MM, Zbar B. The genetic basis of cancer of the kidney. J Urol. 2003;170:2163–72.
Kattan MW, Reuter VE, Motzer RJ, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol. 2001;166:63.
Russo P. Renal cell carcinoma: presentation, staging, and surgical treatment. Semin Oncol. 2000;27:160–76.
Beare JB, McDonald JR. Involvement of renal capsule in surgically removed hypernephroma: gross and histopathological study. J Urol. 1949;61:857–61.
Mortensen H. Transthoracic nephrectomy. J Urol. 1948;60:855.
Robson CJ. Radical nephrectomy for renal cell carcinoma. J Urol. 1963;89:37.
Robson CJ, Churchill BM, Andersen W. The results of radical nephrectomy for renal cell carcinoma. J Urol. 1969;101:297.
Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma: a clinical and pathological study of 309 cases. Cancer. 1971;28:1165–77.
Patel NP, Lavengood RW. Renal cell carcinoma: natural history and results of treatment. J Urol. 1978;119:722.
Sagalowsky AI, Kadesky KT, Ewalt DM, Kennedy TJ. Factors influencing adrenal metastases in renal cell carcinoma. J Urol. 1994;151:1181–4.
Herrlinger JA, Schrott KM, Schott G, et al. What are the benefits of extended dissection of the regional lymph nodes in the therapy of renal cell carcinoma? J Urol. 1991;146:1224.
Ditonno P, Traficante A, Battaglia M, et al. Role of lymphadenectomy in renal cell carcinoma. Prog Clin Biol Res. 1992;378:169.
Robson CJ. Results of radical thoraco-abdominal nephrectomy in the treatment of renal cell carcinoma. Prog Clin Biol Res. 1982;100:481–8.
Russo P. Open radical nephrectomy for localized renal cell carcinoma. In: Vogelzang NJ, editor. Genitourinary oncology. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 725–31.
Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. NEJM. 2001;23:1655–9.
Russo P, O’Brien MF. Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy. Urol Clin North Am. 2008;35:679–86.
Russo P. Multi-modal treatment for metastatic renal cancer – the role of surgery. World J Urol. 2010;28:295–301.
Diblasio CJ, Snyder ME, Russo P. Mini flank supra-eleventh incision for open partial or radical nephrectomy. BJU Int. 2006;97(1):149–56.
Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. J Urol. 2001;166:68.
Sorbellini M, Kattan MW, Snyder ME, et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol. 2005;173:48–51.
Clayman RV, Kavoussi LR, Soper NJ, et al. Laparoscopic nephrectomy: initial case report. J Urol. 1991;146:278.
Dunn MD, Portis AJ, Shalhav AL, et al. Laparoscopic versus open radical nephrectomy: 9-year experience. J Urol. 2000;164:1153–9.
Chan DY, Cadeddu JA, Jarrett TW, et al. Laparoscopic radical nephrectomy: cancer control for renal cell carcinoma. J Urol. 2001;166:2095–100.
Makhoul B, De La Taille A, Vordos D, et al. Laparoscopic radical nephrectomy for T1 renal cancer: the gold standard? A comparison of laparoscopic vs. open nephrectomy. BJU Int. 2004;93:67–70.
Matin S, Gill I, Worley S, Novick AC. Outcome of laparoscopic radical nephrectomy for sporadic 4 cm or less renal tumor with a normal contra lateral kidney. J Urol. 2002;168:1356–60.
Gill IS, Meraney AM, Schweizer DK, et al. Laparoscopic radical nephrectomy in 100 patients. Cancer. 2001;92:1843–55.
Scherr DS, Ng C, Munver R, Sosa ER, Vaughan ED, Del Pizzo J. Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology vs. oncology. Urology. 2003;62:1007–11.
Zorn KC, Gong EM, Orvieto MA, et al. Comparison of laparoscopic radical and partial nephrectomy: effects on long-term serum creatinine. Urology. 2007;69:1035–40.
Nadler RB, Loeb S, Clemens JQ, et al. A prospective study of laparoscopic radical nephrectomy for T1 tumors – is transperitoneal, retroperitoneal, or hand assisted the best approach? J Urol. 2006;4:1230–3.
Hernandez F, Rha KH, Pinto PA, et al. Laparoscopic nephrectomy: assessment of morcellation versus intact specimen extraction of postoperative status. J Urol. 2003;170:412–5.
Viterbo R, Greenberg RE, Al-Saleem T, et al. Prior abdominal surgery and radiation do not complicate the retroperitoneoscopic approach to the kidney or adrenal gland. J Urol. 2005;174:57–60.
Fugita OE, Chan DY, Roberts WW, et al. Laparoscopic radical nephrectomy in obese patients: outcomes and technical considerations. Urology. 2004;63:247–52.
Hemal AK, Kumar A. A prospective comparison of laparoscopic and robotic radical nephrectomy for T1-2N0M0 renal cell carcinoma. World J Urol. 2009;27:89–94.
Stephanson A, Hakimian A, Snyder ME, Russo P. Complications of radical and partial nephrectomy in a large contemporary cohort. J Urol. 2004;171:130–4.
Soulie M, Seguin P, Richeux L, et al. Urological complications of laparoscopic surgery: experience with 350 procedure at a single center. J Urol. 2000;165:1960.
Vallancien G, Cathelineau X, Baumert H, et al. Complications of transperitoneal laparoscopic surgery in urology. Review of 1311 procedures at a single center. J Urol. 2002;168:23–6.
Wile AH, Roigas J, Degor S, et al. Laparoscopic radical nephrectomy: techniques, results, and oncological outcome in 125 consecutive cases. Eur Urol. 2004;45:483–8.
Meraney AM, Samee AA, Gill IS. Vascular and bowel complications during retroperitoneal laparoscopic surgery. J Urol. 2002;168:1941–4.
Kim FJ, Rha KH, Hernandez F, Jarrett TW, Pinto P, Kavoussi L. Laparoscopic radical versus partial nephrectomy: assessment of complications. J Urol. 2003;170:408–11.
Simon SD, Castle EP, Ferrigni RG, et al. Complications of laparoscopic nephrectomy: the Mayo Clinic experience. J Urol. 2004;171:1447–50.
Segev DL, Muzaale AD, Caffo BS, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010;503:959–66.
Fehrman-Ekholm I, Duner F, Brink B, et al. No evidence of loss of kidney function in living kidney donors from cross sectional follow up. Transplantation. 2001;72:444–9.
Goldfarb DA, Matin SF, Braun WE, et al. Renal outcome 25 years after donor nephrectomy. J Urol. 2001;166:2043.
Kaplan C, Pasternack B, Shah H, et al. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol. 1975;80:227.
Bijol V, Mendez GP, Hurwitz S, Rennke HG, Nosé V. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens. Am J Surg Pathol. 2006;30:575.
Lau WK, Blute ML, Weaver AL, et al. Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contra lateral kidney. Mayo Clin Proc. 2000;75:1236–42.
McKiernan J, Simmons R, Katz J, Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology. 2002;59:816–20.
Sarnak M, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for the development of cardiovascular disease: a statement from the American Heart Association Council on kidney in cardiovascular disease. High blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108:2154–69.
Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on TN prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–72.
Kidney Disease Outcome Quality Imitative. K/DOQI clinical guideline for chronic kidney disease evaluation, classification, stratification. Am J Kidney Dis. 2002;39 Suppl 2:51:5246.
Ritz E, McClellan WW. Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences. J Am Soc Nephrol. 2004;15:513–6.
Shlipak MG, Fried LF, Cushman M, et al. Cardiovascular mortality risk in chronic kidney disease. JAMA. 2005;293:1737–45.
Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47.
Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;35:1296–305.
Foley RN, Wang C, Collins AJ. Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES 3 study. Mayo Clin Proc. 2005;80:1270–7.
Stevens LA, Coresh J, Green T, Levey AS. Assessing kidney function – measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473–83.
Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumors: a retrospective cohort study. Lancet Oncol. 2006;7:735–40.
Thompson HR, Boorjian SA, Lohse CM, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared to partial nephrectomy. J Urol. 2008;179:468–73.
Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors – is there a difference in mortality and cardiovascular outcomes. J Urol. 2009;181:55–62.
Tan HJ, Norton EC, Ye Z, Hafez K, Gore JL, Miller DC. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA. 2012;207:1629–35.
Kim SP, Thompson H, Boorjian SA, et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol. 2012;188:51–7.
Foyil KV, Ames CD, Ferguson GG, et al. Long-term changes in creatinine clearance after laparoscopic renal surgery. J Am Coll Surg. 2008;206:511–5.
Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomized EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011;59:543–52.
Lane BR, Poggio ED, Herts BR, Novick AC, Campbell SC. Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J Urol. 2009;182:436–44.
Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182:1271–9.
Hollenback BK, Tash DA, Miller DC, et al. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology. 2006;67:254–9.
Miller DC, Hollingsworth JM, Hafez KS, et al. Partial nephrectomy for small renal masses. An emerging quality of care concern? J Urol. 2006;175:853–7.
Dulabon LM, Lowrance WT, Russo P, Huang WC. Trends in renal tumor surgery delivery within the United States. Cancer. 2010;116:2316–21.
Lowrance WT, Yee DS, Savage C, et al. Complications after radical and partial nephrectomy as a function of age. J Urol. 2010;183:1725–30.
Miller DC, Taub DA, Dunn RL, Wei JT, Hollenbeck BK. Laparoscopy for renal cell carcinoma: diffusion versus regionalization? J Urol. 2006;176:1102–6.
Nuttail M, Cathcart P, van der Meulen J, et al. A description of radical nephrectomy practice and outcomes in England: 1995–2002. BJU Int. 2005;96:58–61.
Thompson HR, Kaag M, Vickers A, et al. Contemporary use of partial nephrectomy at a tertiary care center in the United States. J Urol. 2009;181:993–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Russo, P. (2013). Radical Nephrectomy for Localized Renal Tumors: Optimum Oncological and Renal Functional Considerations. In: Campbell, S., Rini, B. (eds) Renal Cell Carcinoma. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-062-5_7
Download citation
DOI: https://doi.org/10.1007/978-1-62703-062-5_7
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-061-8
Online ISBN: 978-1-62703-062-5
eBook Packages: MedicineMedicine (R0)